GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Oncology: [Formula: see text] Hematology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Geriatrics: [Formula: see text] Public Health: [Formula: see text].

Perinatal depression can have a deleterious impact on mothers and infants.

GIM/FP/GP: [Formula: see text].

Emergency Med: [Formula: see text] GIM/FP/GP: [Formula: see text] Neurology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Hematology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Public Health: [Formula: see text].

Data extraction is a critical but error-prone and labor-intensive task in evidence synthesis. Unlike other artificial intelligence (AI) technologies, large language models (LLMs) do not require labeled training data for data extraction.

GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text].

Urinary albumin-creatinine ratio (UACR) and urinary protein-creatinine ratio (UPCR) are both used in clinical practice to diagnose and monitor chronic kidney disease (CKD). Which measure exhibits stronger associations with clinical outcomes and whether this varies by patient characteristics are unknown.

Safe and reliable venous access is critical for high-quality cancer care. Patients with both solid and hematologic cancers require vascular access devices (VADs) for systemic chemotherapies and for supportive treatments, including blood products, antimicrobials, antiemetics, and fluids. However, VADs are associated with serious complications, including bloodstream infection and venous thromboembolism. Evidence-based guidance could maximize benefits and reduce risks in the selection and management of VADs in patients with cancer. The authors convened a 9-member international multidisciplinary panel and used the RAND/UCLA Appropriateness Method to develop recommendations for VAD selection, insertion, and management in patients with cancer. A literature review informed the development of clinical scenarios, which were rated by the panel for appropriateness based on cancer type, treatment indication, urgency, comorbidities, and anticipated duration of use. Of 1422 scenarios, 502 (35%) were rated as appropriate, 400 (28%) were rated as neutral/uncertain, and 520 (37%) were rated as inappropriate. Appropriateness of VAD selection varied by type of cancer, treatment urgency, and planned dwell time. For patients with acute hematologic cancers requiring urgent chemotherapy, placement of a double-lumen peripherally inserted central catheter (PICC) or a tunneled central venous catheter (CVC) was rated as appropriate, regardless of treatment intensity or infusate characteristics. For patients with malignant solid tumors, a single-lumen tunneled CVC or implanted port was rated as appropriate for delivering chemotherapy, regardless of treatment intensity, urgency, or duration. In patients with advanced chronic kidney disease, coordination of care with a nephrologist to ensure vein preservation in the context of cancer prognosis was recommended. By developing comprehensive, evidence-informed expert recommendations, the Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC-ONC) aims to improve clinical care, reduce complications, support quality improvement efforts, and advance the safety of vascular access for patients with cancer.